TIMP1 influences key aspects of the TME, such as by activating cancer-associated fibroblasts, leading to extracellular matrix remodeling, regulating inflammation, stimulating epithelial–mesenchymal transition and influencing angiogenesis, thereby promoting tumor aggressiveness [13, 33]. The gene discussed is TIMP1; the disease is neoplasm.